TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07455578: Phase 1b, Open-Label, Exploratory Biomarker Basket Study of S-4321 in Participants With an Autoimmune or Immune-Mediated Disease

Sponsor: Seismic Therapeutic AU Pty Ltd · Phase: PHASE1 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 24 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$2,368,440

Rescue Site Savings

+$1,561,416

Unlock Full NCT07455578 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07455578 Rescue Dossier →